RDIF head announces plans to supply 1 billion doses of Sputnik in 2022

By the end of this year, Sputnik Light and Sputnik V vaccines should be produced in quantities sufficient toto vaccinate 700 million people Kirill Dmitriev

In 2022, the number of doses of Sputnik V and Sputnik Light vaccines necessary to vaccinate 1 billion people will be produced. This was stated by the HEAD of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev in an interview with Fortune.

“We expect to deliver doses to approximately 1 billion people next year. We are not trying to become a major player in the market, but we certainly want to make our contribution,” he said (quoted by RIA Novosti).

Dmitriev also specified that by the end of this year, the number of doses of Sputnik V and Sputnik Light sufficient for 700 million people will be produced.

FMBA Institute applied for registration of Mir-19 anti-COVID drug Society

As the head of the Center to them. N.F. Gamaleya Alexander Gintsburg, in total, about 57 million sets of the Sputnik V vaccine were released into civilian circulation.

In addition, in August, the Ministry of Industry and Trade noted an increase in exports of various vaccines from RUSSIA, including Sputnik V. According to the agency, in the first five months of 2021, Russia sold abroad almost twice as many vaccines in value terms than in the previous three years in total. According to the Federal Customs Service (FCS), according to the TN VED classification code 3002200009 (“other vaccines for humans”), from January to May of this year, 159 tons of pharmaceutical products worth $303.6 million were delivered to other countries.

In July, some countries complained about delays in deliveries. Complaints include Argentina and Guatemala. In response, RDIF announced in August that it had signed contracts with 14 manufacturers. The fund promised to increase deliveries in September.

Read on RBC Pro What tax novelties have the authorities prepared for companies You swim shallowly: how does the thinking of a leader differ from the thinking of a performer Russian insurer is going for an IPO with an estimate of up to $1 billionWhat is important to know "Commodity prices can collapse": Katie Wood - on the risks in the stock markets

The Russian vaccine against CORONAVIRUS Sputnik V (based on the adenovirus platform) was registered in Russia on August 11, 2020, and 70 countries approved its use. At the same time, the Russian drug has not yet been recognized by the European Medicines Agency (EMA) and the World HEALTH Organization (WHO).